MFW
PDLI

Mosaic Family Wealth’s PDL BioPharma, Inc. PDLI Stock Holding History

Mosaic Family Wealth’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-204
Closed – – 875
2015
Q4 		$0 Buy
+204
New +$854 ﹤0.01% 797

Other funds holding PDLI

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Mosaic Family Wealth's PDLI Position: Q1 2016 in Review

Mosaic Family Wealth sold out of PDL BioPharma, Inc. (PDLI) in Q1 2016, closing a stake of 204 shares.

Mosaic Family Wealth first reported a position in PDLI in Q4 2015 and held it in 1 quarter. The position peaked at $0 in Q4 2015. 195 funds tracked by Wall St. Rank hold PDLI as of Q1 2016.

  • Mosaic Family Wealth reported no remaining PDL BioPharma, Inc. position as of Q1 2016 after selling out during the quarter.
  • Mosaic Family Wealth sold 204 PDL BioPharma, Inc. shares in Q1 2016.
  • Mosaic Family Wealth first reported a position in PDL BioPharma, Inc. in Q4 2015 and held it in 1 quarter.
  • Mosaic Family Wealth's PDL BioPharma, Inc. position peaked at $0 in Q4 2015.
  • 195 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2016.

Based on Mosaic Family Wealth's 13F filing for Q1 2016, filed 12 May 2016.